Stefan Leucht

Stefan Leucht

Auto-generated profile, based on publicly available information

Stefan Leucht

Technical University of Munich, School of Medicine and Health, Department of Psychiatry and Psychotherapy, TUM University Hospital, Munich, Germany

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2021 in The Lancet Psychiatry
Verified
Journal Article
Open access
IBIrene Bighelli
Irene Bighelli
ARAlessandro Rodolico
Alessandro Rodolico
HGHelena García-Mieres
Helena García-Mieres
GPGabi Pitschel-Walz
Gabi Pitschel-Walz
WHWulf-Peter Hansen
Wulf-Peter Hansen
SLStefan Leucht
Stefan Leucht
Many psychosocial and psychological interventions are used in patients with schizophrenia, but their comparative efficacy in the prevention of relapse is not known. We aimed to evaluate the efficacy, acceptability, and tolerability of psychosocial and psychological interventions for relapse prevention in schizophrenia. To conduct this systematic review and network meta-analysis we searched for published and unpublished randomised controlled trials that investigated psychosocial or psychological interventions aimed at preventing relapse in patients with schizophrenia. We searched EMBASE, MEDLINE, PsycINFO, BIOSIS, Cochrane Library, WHO International Clinical Trials Registry Platform, and ClinicalTrials.gov up to Jan 20, 2020, and searched PubMed up to April 14, 2020. We included open and masked studies done in adults with schizophrenia or related disorders. We excluded studies in which all patients were acutely ill, had a concomitant medical or psychiatric disorder, or were prodromal or "at risk of psychosis". Study selection and data extraction were done by two reviewers independently based on published and unpublished reports, and by contacting study authors. Data were extracted about efficacy, tolerability, and acceptability of the interventions; potential effect moderators; and study quality and characteristics. The primary outcome was relapse measured with operationalised criteria or psychiatric hospital admissions. We did random-effects network meta-analysis to calculate odds ratios (ORs) or standardised mean differences (SMDs) with 95% CIs. The study protocol was registered with PROSPERO, CRD42019147884. We identified 27 765 studies through the database search and 330 through references of previous reviews and studies. We screened 28 000 records after duplicates were removed. 24 406 records were excluded by title and abstract screening and 3594 full-text articles were assessed for eligibility. 3350 articles were then excluded for a variety of reasons, and 244 full-text articles corresponding to 85 studies were included in the qualitative synthesis. Of these, 72 studies with 10 364 participants (3939 females and 5716 males with sex indicated) were included in the network meta-analysis. The randomised controlled trials included compared 20 psychological interventions given mainly as add-on to antipsychotics. Ethnicity data were not available. Family interventions (OR 0·35, 95% CI 0·24-0·52), relapse prevention programmes (OR 0·33, 0·14-0·79), cognitive behavioural therapy (OR 0·45, 0·27-0·75), family psychoeducation (OR 0·56, 0·39-0·82), integrated interventions (OR 0·62, 0·44-0·87), and patient psychoeducation (OR 0·63, 0·42-0·94) reduced relapse more than treatment as usual at 1 year. The confidence in the estimates ranged from moderate to very low. We found no indication of publication bias. We found robust benefits in reducing the risk of relapse for family interventions, family psychoeducation, and cognitive behavioral therapy. These treatments should be the first psychosocial interventions to be considered in the long-term treatment for patients with schizophrenia. German Ministry for Education and Research.

24 February 2022 in The Lancet
Verified
Journal Article
Closed access
JSJohannes Schneider-Thoma
Johannes Schneider-Thoma
KCKonstantina Chalkou
Konstantina Chalkou
CDCarola Dörries
Carola Dörries
IBIrene Bighelli
Irene Bighelli
ACAnna Ceraso
Anna Ceraso
SLStefan Leucht
Stefan Leucht

24 January 2018 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
MKMarc Krause
Marc Krause
YZYikang Zhu
Yikang Zhu
MHMaximilian Huhn
Maximilian Huhn
JSJohannes Schneider-Thoma
Johannes Schneider-Thoma
IBIrene Bighelli
Irene Bighelli
SLStefan Leucht
Stefan Leucht

19 July 2016 in European Archives of Psychiatry and Clinical Neuroscience
Verified
Journal Article
Closed access
PDF file
SLStefan Leucht
Stefan Leucht
ACAnna Chaimani
Anna Chaimani
ACAndrea S. Cipriani
Andrea S. Cipriani
JDJohn M. Davis
John M. Davis
TFToshi A. Furukawa
Toshi A. Furukawa
GSGeorgia Salanti
Georgia Salanti

18 October 2022 in Annals of Internal Medicine
Verified
Journal Article
Open access
GSGeorgia Salanti
Georgia Salanti
NPNatalie Peter
Natalie Peter
MTMsc Thomy Tonia
Msc Thomy Tonia
MHMsc Alexander Holloway
Msc Alexander Holloway
IWIan R. White
Ian R. White
MIMHCOVID Crowd Investigators†
MHCOVID Crowd Investigators†
This systematic review uses novel methods to describe mental health symptoms during the first year of the COVID-19 pandemic and how they relate to days since the start of the pandemic, stringency o... Background: To what extent the COVID-19 pandemic and its containment measures influenced mental health in the general population is still unclear. Purpose: To assess the trajectory of mental health...

31 January 2022 in The Lancet Psychiatry
Verified
Journal Article
Closed access
ARAlessandro Rodolico
Alessandro Rodolico
IBIrene Bighelli
Irene Bighelli
CAChiara Avanzato
Chiara Avanzato
CCCarmen Concerto
Carmen Concerto
PCPierfelice Cutrufelli
Pierfelice Cutrufelli
SLStefan Leucht
Stefan Leucht